Takeda Triumphs In Suits To Block Generic Dexilant

Law360, New York (November 4, 2013, 1:44 PM EST) -- Takeda Pharmaceutical Co. Ltd. on Friday scored victories in three of its patent infringement suits in California federal court against drugmakers looking to sell a generic version of its acid reflux medicine Dexilant, convincing the court that a total of four of its patents would be infringed if the generics went to market.

U.S. District Judge Joseph C. Spero handed down the three brief judgments based on a series of factual findings made on Oct. 17, which are still under seal by the court. Judge Spero...
To view the full article, register now.